Suzanne M. Filteau
Research Subjects
Suzanne M. Filteau has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Amy L Rice
From the Centre for International Child Health, Institute of Child Health, London; the London School of Hygiene and Tropical Medicine; Johns Hopkins University, Baltimore; and the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research
1 shared publicationAndres de Francisco
From the Centre for International Child Health, Institute of Child Health, London; the London School of Hygiene and Tropical Medicine; Johns Hopkins University, Baltimore; and the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research
1 shared publicationAndrew M. Tomkins
1 shared publicationAnna Coutsoudis
1 shared publicationJ Chakraborty
From the Centre for International Child Health, Institute of Child Health, London; the London School of Hygiene and Tropical Medicine; Johns Hopkins University, Baltimore; and the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research
1 shared publicationJennifer J Ball
From the Centre for International Child Health, Institute of Child Health, London; the London School of Hygiene and Tropical Medicine; Johns Hopkins University, Baltimore; and the International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research
1 shared publication
Latest Publications
- 1 September 2004
- Published by Wiley in Acta Paediatrica
- Vol. 93 (9) , 1156-1158
Low-cost intervention to decrease mastitis among lactating women
Mastitis is a common maternal health problem which can lead to serious infant health problems such as poor growth and HIV infection. Anti‐secretory factor (AF), which can be induced in milk by maternal consumption of a low‐cost cereal product, has been associated with decreased mastitis. Conclusion: Consumption of cereals which induce AF should be investigated as a potential intervention in less‐developed countries where the consequences of mastitis for infants are most severe.
- 1 September 2004
- Published by Wiley in Acta Paediatrica
- Vol. 93 (9) , 1156-1158
Low-cost intervention to decrease mastitis among lactating women
Mastitis is a common maternal health problem which can lead to serious infant health problems such as poor growth and HIV infection. Anti‐secretory factor (AF), which can be induced in milk by maternal consumption of a low‐cost cereal product, has been associated with decreased mastitis. Conclusion: Consumption of cereals which induce AF should be investigated as a potential intervention in less‐developed countries where the consequences of mastitis for infants are most severe.
- 1 January 2003
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 97 (1) , 25-29
Infant-feeding strategies to prevent post-natal HIV transmission
Promotion of breastfeeding is a key component of infant health policies globally. However, maternal HIV infection is a possible contraindication for
- 1 January 2003
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 97 (1) , 25-29
Infant-feeding strategies to prevent post-natal HIV transmission
Promotion of breastfeeding is a key component of infant health policies globally. However, maternal HIV infection is a possible contraindication for
- 1 April 2001
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 32 (4) , 464-470
The Effect of Antenatal Vitamin A and β-Carotene Supplementation on Gut Integrity of Infants of HIV-Infected South African Women
Vitamin A is important for protection against diarrhea, and supplements may benefit gut function of infants of HIV-infected mothers. We studied 238 infants of HIV-infected South African women participating in a randomized, double-blind, placebo-controlled trial of vitamin A during pregnancy (1.5 mg retinyl palmitate and 30 mg beta-carotene daily) plus 60 mg retinyl palmitate at delivery. The placebo group received identical placebo capsules at the same times. When infants were 1, 6, and 14 weeks of age, lactulose/mannitol dual sugar intestinal permeability tests were performed. Maternal vitamin A supplementation did not significantly affect infant gut permeability in the group as a whole at any time. By multiple regression analysis, HIV infection of the infant by 14 weeks was significantly associated with increased gut permeability at both 6 and 14 weeks. After controlling for birth weight, gestational age, current weight, feeding mode and recent morbidity, there was a trend toward an interaction between vitamin A supplementation and HIV infection (P = 0.086) at 14 weeks. Vitamin A made no difference to gut permeability of uninfected infants (lactulose/mannitol ratio for vitamin A group: 0.11, 95% confidence interval [CI] 0.08, 0.15, n = 73 and for placebo group: 0.09, 95% CI 0.06, 0.12, n = 76), but largely prevented the increase in the ratio of HIV-infected infants (vitamin A group: 0.17, 95% CI 0.13, 0.23, n = 23; placebo group: 0.50, 95% CI 0.37, 0.68, n = 20). The effects on the lactulose/mannitol ratio were related to changes in lactulose, not mannitol, excretion. Vitamin A supplementation was associated with significantly lower lactulose excretion at 1 and 14 weeks, suggesting the major effect of vitamin A was on maintaining the integrity of gut tight junctions. Vitamin A supplementation of HIV-infected pregnant women may prevent the deterioration in gut integrity in the subgroup of their infants who themselves become infected. Improving vitamin A status of HIV-infected infants may decrease their gastrointestinal morbidity.
- 1 April 2001
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 32 (4) , 464-470
The Effect of Antenatal Vitamin A and β-Carotene Supplementation on Gut Integrity of Infants of HIV-Infected South African Women
Vitamin A is important for protection against diarrhea, and supplements may benefit gut function of infants of HIV-infected mothers. We studied 238 infants of HIV-infected South African women participating in a randomized, double-blind, placebo-controlled trial of vitamin A during pregnancy (1.5 mg retinyl palmitate and 30 mg beta-carotene daily) plus 60 mg retinyl palmitate at delivery. The placebo group received identical placebo capsules at the same times. When infants were 1, 6, and 14 weeks of age, lactulose/mannitol dual sugar intestinal permeability tests were performed. Maternal vitamin A supplementation did not significantly affect infant gut permeability in the group as a whole at any time. By multiple regression analysis, HIV infection of the infant by 14 weeks was significantly associated with increased gut permeability at both 6 and 14 weeks. After controlling for birth weight, gestational age, current weight, feeding mode and recent morbidity, there was a trend toward an interaction between vitamin A supplementation and HIV infection (P = 0.086) at 14 weeks. Vitamin A made no difference to gut permeability of uninfected infants (lactulose/mannitol ratio for vitamin A group: 0.11, 95% confidence interval [CI] 0.08, 0.15, n = 73 and for placebo group: 0.09, 95% CI 0.06, 0.12, n = 76), but largely prevented the increase in the ratio of HIV-infected infants (vitamin A group: 0.17, 95% CI 0.13, 0.23, n = 23; placebo group: 0.50, 95% CI 0.37, 0.68, n = 20). The effects on the lactulose/mannitol ratio were related to changes in lactulose, not mannitol, excretion. Vitamin A supplementation was associated with significantly lower lactulose excretion at 1 and 14 weeks, suggesting the major effect of vitamin A was on maintaining the integrity of gut tight junctions. Vitamin A supplementation of HIV-infected pregnant women may prevent the deterioration in gut integrity in the subgroup of their infants who themselves become infected. Improving vitamin A status of HIV-infected infants may decrease their gastrointestinal morbidity.
- 1 May 1999
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 69 (5) , 953-958
Breast milk immune factors in Bangladeshi women supplemented postpartum with retinol or β-carotene
Background: Vitamin A supplementation of mothers postpartum may improve infant health, not only by increasing vitamin A delivery to the infant through breast milk but also by increasing delivery of milk immune factors. Our hypothesis was that postpartum supplementation with vitamin A increases milk concentrations of certain soluble immune factors. Design: In a double-blind trial conducted in Matlab, Bangladesh, women at 1–3 wk postpartum were randomly assigned to receive until 9 mo postpartum 1) a single dose of 60 mg retinol as retinyl palmitate followed by daily placebos (n = 69), 2) daily doses of 7.6 mg β-carotene (n = 72), or 3) daily placebos (n = 71). Milk samples collected at baseline and 3 mo postpartum were analyzed by enzyme-linked immunosorbent assay for secretory immunoglobulin A, lactoferrin, lysozyme, and interleukin 8; by HPLC for total retinol; and by atomic absorption spectroscopy for sodium and potassium. Results: After mammary epithelial permeability (defined as an elevated Na:K) and baseline immune factor concentrations were controlled for, there were no significant treatment effects on immune factors at 3 mo. Increased mammary permeability was common (25% of women at baseline and 12% at 3 mo) and was associated with higher concentrations of milk immune factors. Low body vitamin A stores at baseline, as assessed by the modified-relative-dose-response test, were associated with a higher Na:K, but neither retinol nor β-carotene supplementation affected the prevalence of increased mammary permeability. Conclusions: Postpartum vitamin A supplementation does not increase milk concentrations of immune factors. The causes of increased mammary epithelial permeability in this population require further study.
- 1 May 1999
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 69 (5) , 953-958
Breast milk immune factors in Bangladeshi women supplemented postpartum with retinol or β-carotene
Background: Vitamin A supplementation of mothers postpartum may improve infant health, not only by increasing vitamin A delivery to the infant through breast milk but also by increasing delivery of milk immune factors. Our hypothesis was that postpartum supplementation with vitamin A increases milk concentrations of certain soluble immune factors. Design: In a double-blind trial conducted in Matlab, Bangladesh, women at 1–3 wk postpartum were randomly assigned to receive until 9 mo postpartum 1) a single dose of 60 mg retinol as retinyl palmitate followed by daily placebos (n = 69), 2) daily doses of 7.6 mg β-carotene (n = 72), or 3) daily placebos (n = 71). Milk samples collected at baseline and 3 mo postpartum were analyzed by enzyme-linked immunosorbent assay for secretory immunoglobulin A, lactoferrin, lysozyme, and interleukin 8; by HPLC for total retinol; and by atomic absorption spectroscopy for sodium and potassium. Results: After mammary epithelial permeability (defined as an elevated Na:K) and baseline immune factor concentrations were controlled for, there were no significant treatment effects on immune factors at 3 mo. Increased mammary permeability was common (25% of women at baseline and 12% at 3 mo) and was associated with higher concentrations of milk immune factors. Low body vitamin A stores at baseline, as assessed by the modified-relative-dose-response test, were associated with a higher Na:K, but neither retinol nor β-carotene supplementation affected the prevalence of increased mammary permeability. Conclusions: Postpartum vitamin A supplementation does not increase milk concentrations of immune factors. The causes of increased mammary epithelial permeability in this population require further study.
- 1 July 1998
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 80 (1) , 75-79
Vitamin A status does not influence neopterin production during illness or health in South African children
Excessive interferon-gamma (IFN-γ) production appears to be a primary immunological lesion in vitamin A-deficient experimental animals but comparable data from humans is lacking. We investigated IFN-γ production in South African children by measurement of urinary excretion of neopterin, a product of IFN-γ-activated monocytes or macrophages. Preschool children were examined during an acute inflammatory illness resulting from accidental ingestion of kerosene and they and a neighbourhood control child were examined 3 months later when well. Vitamin A status was assessed by the modified relative dose response (MRDR) test at 3 months and serum retinol and acute phase proteins were measured at both time points. Urinary neopterin was measured for forty cases in hospital, forty-six cases after recovery, and forty-one controls. Significantly increased neopterin excretion was seen following kerosene ingestion and in association with raised serum acute phase protein concentrations. There was no relationship between neopterin excretion at either time point and vitamin A status as assessed by MRDR test. Urinary neopterin was negatively correlated with serum retinol but no significant relationship was observed when acute phase protein concentrations were included in a multiple regression, suggesting the correlation was secondary to illness-induced changes in serum retinol. The results indicate that, contrary to what is observed in rodents under experimental conditions, poor vitamin A status is not associated with altered regulation of IFN-γ production in children.
- 1 July 1998
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 80 (1) , 75-79
Vitamin A status does not influence neopterin production during illness or health in South African children
Excessive interferon-gamma (IFN-γ) production appears to be a primary immunological lesion in vitamin A-deficient experimental animals but comparable data from humans is lacking. We investigated IFN-γ production in South African children by measurement of urinary excretion of neopterin, a product of IFN-γ-activated monocytes or macrophages. Preschool children were examined during an acute inflammatory illness resulting from accidental ingestion of kerosene and they and a neighbourhood control child were examined 3 months later when well. Vitamin A status was assessed by the modified relative dose response (MRDR) test at 3 months and serum retinol and acute phase proteins were measured at both time points. Urinary neopterin was measured for forty cases in hospital, forty-six cases after recovery, and forty-one controls. Significantly increased neopterin excretion was seen following kerosene ingestion and in association with raised serum acute phase protein concentrations. There was no relationship between neopterin excretion at either time point and vitamin A status as assessed by MRDR test. Urinary neopterin was negatively correlated with serum retinol but no significant relationship was observed when acute phase protein concentrations were included in a multiple regression, suggesting the correlation was secondary to illness-induced changes in serum retinol. The results indicate that, contrary to what is observed in rodents under experimental conditions, poor vitamin A status is not associated with altered regulation of IFN-γ production in children.